- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
Patent holdings for IPC class C07K 16/18
Total number of patents in this class: 11488
10-year publication summary
|
953
|
948
|
1016
|
965
|
1034
|
936
|
913
|
829
|
738
|
195
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1146 |
230 |
| Alexion Pharmaceuticals, Inc. | 619 |
170 |
| Genentech, Inc. | 3898 |
165 |
| Ablynx N.V. | 391 |
139 |
| The Regents of the University of California | 19681 |
138 |
| Amgen Inc. | 3985 |
118 |
| Regeneron Pharmaceuticals, Inc. | 4140 |
118 |
| Chugai Seiyaku Kabushiki Kaisha | 1319 |
106 |
| F. Hoffmann-La Roche AG | 7889 |
105 |
| Prothena Biosciences Limited | 186 |
99 |
| Eli Lilly and Company | 3773 |
95 |
| AC Immune S.A. | 246 |
86 |
| Hoffmann-La Roche Inc. | 3344 |
83 |
| H. Lundbeck A/S | 1187 |
81 |
| The Trustees of the University of Pennsylvania | 4282 |
76 |
| Novartis AG | 11042 |
74 |
| Sanofi | 3980 |
74 |
| Bristol-myers Squibb Company | 4848 |
59 |
| The Johns Hopkins University | 5575 |
56 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
56 |
| Other owners | 9360 |